-
PH Treated in Early Study by Raising Levels of Immune Cell Receptor, TLR3
An early study suggests that a receptor protein present in immune cells, called TLR3, is a potential target for treating pulmonary hypertension. Read more about the study and its findings here.
Are you interested in this research?
Sorry, there were no replies found.
Log in to reply.